We are live on ! Find out more
SVA

Sinovac Biotech, Ltd
SVA

Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

23 hedge funds and large institutions have $36.7M invested in Sinovac Biotech, Ltd in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

4% less funds holding

Funds holding: 24 → 23 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

51% less capital invested

Capital invested by funds: $74.7M → $36.7M (-$38M)

Holders
23
Holders Change
-1
Holders Change %
-4.17%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
2
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$259K

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$38.2M
2
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$33K
3
TRCT
Tower Research Capital (TRC)
New York
-$3K
4
FIM
Freedom Investment Management
Connecticut
-$207
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$16.6M – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$15.4M – – –
NAH
3
Neumann Advisory (HK)
Hong Kong
$2.04M – – –
State Street
4
State Street
Massachusetts
$1.04M – – –
YMRC
5
Yorktown Management & Research Company
Virginia
$485K – – –
California Public Employees Retirement System
6
California Public Employees Retirement System
California
$445K – – –
Skandinaviska Enskilda Banken (SEB)
7
Skandinaviska Enskilda Banken (SEB)
Sweden
$259K +$259K +40,000 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$179K – – –
FIM
9
Freedom Investment Management
Connecticut
$134K -$207 -32 -0.2%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$106K – – –
Northern Trust
11
Northern Trust
Illinois
$55K – – –
Morgan Stanley
12
Morgan Stanley
New York
$9K – – –
Group One Trading
13
Group One Trading
Illinois
$3K – – –
FGAM
14
Financial Gravity Asset Management
Texas
$1K – – –
VC
15
Vivo Capital
California
– -$38.2M -5,900,000 Closed
Parallax Volatility Advisers
16
Parallax Volatility Advisers
California
– -$33K -5,055 Closed
TRCT
17
Tower Research Capital (TRC)
New York
– -$3K -424 Closed

SVA Hedge Fund Activity: Q3 2019 in Review

23 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q3 2019, worth a combined $36.7M — down 51% from $74.7M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of SVA and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Skandinaviska Enskilda Banken (SEB), opening a new position worth an estimated $259K. The largest seller was Vivo Capital, exiting entirely with an estimated $38.2M sold.

  • 23 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q3 2019, down from 24 in Q2 2019.
  • Funds reported $36.7M of Sinovac Biotech, Ltd stock for Q3 2019, down 51% quarter-over-quarter.
  • 2 funds opened new Sinovac Biotech, Ltd positions in Q3 2019 and 3 closed out, a net change of -1 holder.
  • The largest Sinovac Biotech, Ltd buyer in Q3 2019 was Skandinaviska Enskilda Banken (SEB), an estimated $259K added.
  • The largest Sinovac Biotech, Ltd seller in Q3 2019 was Vivo Capital, an estimated $38.2M sold.

Based on aggregated 13F filings for Q3 2019.